COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03180840
Brief Title: Study of the Safety, Efficacy, & PK of Pegunigalsidase Alfa (PRX-102) 2 mg/kg IV Administered Every 4 Weeks in Fabry Disease Patients (BRIGHT)

First Submitted : May 29, 2017
First Submitted that Met QC Criteria : June 7, 2017
First Posted : June 8, 2017

Last Update Submitted that Met QC Criteria : September 25, 2019
Last Update Posted : September 26, 2019